HRF

HRF (Hormone Research Foundation) is a South Korean biotechnology company focused on the development of novel therapeutics targeting Histamine-Releasing Factor (HRF), also known as Translationally-Controlled Tumor Protein (TCTP). The company specializes in identifying and developing inhibitors and modulators of HRF to treat various inflammatory and allergic diseases, including asthma and atopic dermatitis. By leveraging its deep expertise in hormone and cytokine research, HRF aims to address unmet medical needs in the immunology and oncology sectors. Their research pipeline primarily consists of pre-clinical candidates designed to block the extracellular pro-inflammatory activities of HRF.